Ok, so what you're saying is that with this mass dilution, it will lower the stock price even more, below the resistance level, so that even if the FDA approved Nuplazid for APD, that the stock price would still go lower, due to the massive and irresponsible dilution and that Acadia does not care in the slightest bit for their retail investors?
News 
Market Data 
Discover 
